Journal of Attention Disorders

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Click here for more information

Sign In to gain access to subscriptions and/or personal tools.
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wilens, T. E.
Right arrow Articles by Biederman, J.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Wilens, T. E.
Right arrow Articles by Biederman, J.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
Journal of Attention Disorders, Vol. 5, No. 4, 189-202 (2001)
DOI: 10.1177/108705470100500401
© 2001 SAGE Publications

Reviews

A review of the pharmacotherapy of adults with Attention-Deficit/ Hyperactivity Disorder

Timothy E. Wilens

Clinical Research Program in Pediatric Psychopharmacology, Massachusetts. General Hospital and Harvard Medical School.

Thomas J. Spencer

Clinical Research Program in Pediatric Psychopharmacology, Massachusetts. General Hospital and Harvard Medical School.

Joseph Biederman

Clinical Research Program in Pediatric Psychopharmacology, Massachusetts. General Hospital and Harvard Medical School.

Objective: Despite the increasing recognition of attention deficit hyperactivity disorder (ADHD) in adults, the use of pharmacotherapeutics remains less established.

Methods: A systematic review of the literature identified 15 studies (N = 435 subjects) of stimulants, and 22 studies of non- stimulant medications (N = 421 subjects) including antidepressants, antihypertensives, amino acids, and wake-promoting agents for the treatment of ADHD in adults.

Results: Studies with stimulants and antidepressants demonstrated significant short-term improvement in ADHD symptoms compared to placebo in adults. Methylphenidate (MPH) and amphetamine had an immediate onset of action whereas the ADHD response to pemoline and antidepressants appeared delayed. The response to amphetamine and MPH appears to be dose-dependent. Controlled data on nicotonic and noradrenergic compounds appear promising. There was considerable variability In diagnostic criteria, dosing parameters, and response rates between the various studies.

Conclusions: Under controlled conditions, the aggregate literature shows that the stimulants and noradrenergic antidepressants had a clinically and statistically significant beneficial effect on treating ADHD in adults.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?